WHO ICTRP trial
Effect of Ascorbic acid on hematologic status among Pregnant women, attending…
TCTR20201105006 · Thai Clinical Trials Registry (TCTR) · Recruiting
Key facts
| Trial ID | TCTR20201105006 |
|---|---|
| Public title | Effect of Ascorbic acid on hematologic status among Pregnant women, attending antenatal clinic in Phramongkutklao hospital |
| Scientific title | Effect of Ascorbic acid on hematologic status among Pregnant women,attending antenatal clinic in Phramongkutklao hospital |
| Primary sponsor | Phramongkutklao College of Medicine |
| Secondary sponsors | Phramongkulklao hospital |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 1/Phase 2 |
| Countries | Thailand |
| Conditions | Healthy pregnant women No hematological diasease |
| Interventions | Ferrous fumarate 2oo mg oral daily,Ferrous fumarate 2oo mg oral daily plus Ascobic acid 500 mg oral daily;Placebo Comparator Drug,Experimental Drug;Control group,Intervention group |
| Registration date | May 11, 2020 |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: